前往化源商城

3,3′,5-三碘-L-甲状腺素-13C6

更新时间:2024-04-08 21:06:53

3,3′,5-三碘-L-甲状腺素-13C6结构式
3,3′,5-三碘-L-甲状腺素-13C6结构式
品牌特惠专场
常用名 3,3′,5-三碘-L-甲状腺素-13C6 英文名 Liothyronine-13C6-1
CAS号 1213431-76-5 分子量 656.93
密度 N/A 沸点 N/A
分子式 13C6C9H12I3NO4 熔点 N/A
MSDS N/A 闪点 9 °C
符号 GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
信号词 Danger

 3,3′,5-三碘-L-甲状腺素-13C6用途


内标3,3´,5--三碘-L-甲状腺原氨酸--13C6(T3-13C6)的Certified Spiking Solution®。3,3′,5-三碘-L-甲状腺原氨酸(T3)是一种甲状腺激素,参与人体生长发育、代谢、体温和心率等多种生理过程。该内标适用于LC-MS/MS法定量检测血清游离T3和总T3水平,以测定由过量T3引起的甲亢。

 3,3′,5-三碘-L-甲状腺素-13C6名称

中文名 3,3′,5-三碘-L-甲状腺素-13C6
英文名 3,3′,5-Triiodo-L-thyronine-13C6 solution

 3,3′,5-三碘-L-甲状腺素-13C6物理化学性质

分子式 13C6C9H12I3NO4
分子量 656.93
外观性状 liquid

 3,3′,5-三碘-L-甲状腺素-13C6安全信息

符号 GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
信号词 Danger
危害声明 H225-H301 + H311 + H331-H370
警示性声明 P210-P260-P280-P301 + P310-P311
危险品运输编码 UN1230 - class 3 - PG 2 - Methanol, solution
闪点(华氏) 48.2 °F
闪点(摄氏) 9 °C

 3,3′,5-三碘-L-甲状腺素-13C6文献45

更多文献
Psychometric assessment of the Rat Grimace Scale and development of an analgesic intervention score.

PLoS ONE 9(5) , e97882, (2014)

Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measu...

Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.

Crit. Rev. Oncol. Hematol. , doi:10.1016/j.critrevonc.2014.04.004, (2014)

Arterial thromboembolic events (ATEs) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have emerged as a serious concern, we perform a meta-analysis of randomiz...

Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.

Strahlenther. Onkol. , (2014)

The purpose of this study was to analyze the mode of relapse patterns and survival of 209 patients with stage IVA and IVB nasopharyngeal carcinoma (NPC).A total of 209 patients who underwent magnetic ...